Pretreatment with an irreversible muscarinic agonist affects responses to apomorphine
- 1 March 1990
- journal article
- research article
- Published by Elsevier in Pharmacology Biochemistry and Behavior
- Vol. 35 (3) , 511-516
- https://doi.org/10.1016/0091-3057(90)90281-l
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- RECEPTOR ALKYLATING AGENTS: NOVEL TOOLS FOR THE STUDY OF RECEPTOR FUNCTION IN THE CENTRAL NERVOUS SYSTEM OF THE RATClinical and Experimental Pharmacology and Physiology, 1989
- Effects of adrenalectomy on responses mediated by dopamine D-1 and D-2 receptorsEuropean Journal of Pharmacology, 1989
- Localization of striatal dopamine receptor function by central injection of an irreversible receptor antagonistNeuroscience, 1989
- Adrenocortical hormone status affects responses to dopamine receptor agonistsEuropean Journal of Pharmacology, 1988
- A fixed interval momentary sampling method for assessing on-going behaviours induced by dopamine receptor agonistsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1988
- The effects of selective dopamine receptor agonists and antagonists on body temperature in ratsEuropean Journal of Pharmacology, 1987
- Hypothyroidism leads to incresed dopamine receptor sensitivity and concentrationPharmacology Biochemistry and Behavior, 1986
- An alkylating derivative of oxotremorine interacts irreversibly with the muscarinic receptorLife Sciences, 1984
- Cholinergic Mechanism in Brain inhibiting Amphetamine‐induced Stereotyped BehaviourActa Pharmacologica et Toxicologica, 1968
- The Up-and-Down Method for Small SamplesJournal of the American Statistical Association, 1965